StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Ajit Mishra, Religare

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byAjit Mishra, ReligareHorizon: NA (inferred Swing (≤2wk))15 Jul 2026via ET Now

Entry₹1,953.4Inferred
Target₹2,090
Total upside +6.99% (call closed)
Stop loss₹1,880-3.76% risk
At expiry₹1,99129 Jul 2026, 3:30 pm
Expired+1.92%
Follow Ajit Mishra for new calls(22% target hit, 114 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Jul 2026
4 supporting1 opposing
Supports the BUY call (4)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·27 Jul · 2d ago

Sun Pharma announced that Organon shareholders have approved the proposed acquisition, moving forward the company's strategic expansion plans.

BSE · Company Update·24 Jul · 5d ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·24 Jul · 5d ago

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Pharma stocks: Sun Pharma, Biocon, Dr Reddy's, Torrent Pharma slip on Trump's generic drug tariff plan

NewsGoogle News·23 Jul · 6d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Ajit Mishra, Religare

Every call and its outcome